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Abstract
Introduction. The aim of the study was to characterize the changes in the microcirculation in patients 
with varying severity of atherosclerotic ischaemia of the lower limbs (PAOD).
Material and methods. The study included 27 healthy subjects, 79 patients with PAOD category 
0 and 1 according to the Rutherford classification, and 137 patients with PAOD category 3 and 4. The 
study evaluated cutaneous blood flow, flowmotion bonds, percutaneous partial pressure of oxygen and 
flow-mediated vasodilation.
Results. Even mild PAOD exhibits a worse systemic vascular function expressed as a reduction in the scope 
of flow-mediated vasodilation, and locally in TcpO2 decrease. Increase in local changes in advanced forms of 
PAOD were observed as further reduction in TcpO2 and a drastic reduction or exhaustion of the functional 
microcirculatory reserve. Among the evaluated risk factors for atherosclerosis only diabetes and smoking 
significantly modified perfusion, which resulted in a significant decrease in the values of vasodilation and TcpO2.
Conclusions. The study revealed the occurrence of adverse changes in microcirculation, also in patients 
with poorly discernible signs of limb ischaemia. It can be assumed that these may also occur in the patients 
who underwent a haemodynamically effective revascularization.
Key words: skin microcirculation, flowmotion, atherosclerotic limb ischaemia, percutaneous 
partial pressure of oxygen, flow-mediated vasodilation
Streszczenie
Wstęp. Celem badań było scharakteryzowanie zmian w mikrokrążeniu u pacjentów z różnym stopniem 
zaawansowania miażdżycowego niedokrwienia kończyn dolnych (PAOD).
ORIGINAL PAPER
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Materiał i metody. Do badania włączono 27 zdrowych osób, 79 pacjentów z PAOD w 0 i 1 kategorii 
oraz 137 pacjentów z PAOD w 3 i 4 kategorii według klasyfikacji Rutherforda. Oceniano skórny przepływ 
krwi, pasma flowmotion, przezskórne ciśnienie parcjalne tlenu i wazodylatację indukowaną przepływem.
Wyniki. Już w łagodnej postaci PAOD występuje ogólnoustrojowe pogorszenie funkcji naczyń, wyrażone 
zmniejszeniem zakresu wazodylatacji indukowanej przepływem, a miejscowo zmniejszeniem TcpO2. W za-
awansowanych postaciach PAOD obserwowano pogłębienie zmian miejscowych w postaci dalszego obniże-
nia TcpO2 i radykalnego zmniejszenia lub też wyczerpania rezerwy czynnościowej mikrokrążenia. Spośród 
ocenianych czynników ryzyka rozwoju miażdżycy tylko cukrzyca i palenie tytoniu znamiennie modyfikowały 
perfuzję, istotnie zmniejszając wartości wazodylatacji i TcpO2. 
Wnioski. W przeprowadzonym badaniu wykazano występowanie niekorzystnych zmian w mikrokrążeniu 
także u pacjentów ze słabo zaznaczonymi objawami niedokrwienia kończyn. Można przypuszczać, że 
mogą one występować również u pacjentów po skutecznych hemodynamicznie zabiegach rewaskularyzacji.
Słowa kluczowe: mikrokrążenie skórne, flowmotion, miażdżycowe niedokrwienie kończyn, 
przezskórne ciśnienie parcjalne tlenu, wazodylatacja indukowana przepływem
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Introduction
Evaluation of the efficacy of peripheral revasculariza-
tion is mainly based on the subjective experience of the 
patient, increase in the temperature of the integuments 
and improvement in the flow within the main arterial 
trunks [1]. The latter is not always synonymous with 
an improvement in the degree of integumental perfu-
sion. To date, the parameters of microcirculation have 
not been characterized in varying degrees of severity for 
atherosclerotic limb ischaemia, which could otherwise 
become the basis of objective assessment of the extent 
of peripheral perfusion impairment.
This condition is derived from three problems. Apart 
from a few cases of microvascular parameters, the stu-
dies related to patients with atherosclerotic limb ischae-
mia in stage II according to the Fontaine classification 
[2, 3]. However, considering the qualification criteria 
for revascularization of patients with PAOD, it seems 
that despite the difficulty with completing uniform and 
sufficiently large research groups, it would be more 
appropriate for the study to consider patients with 
advanced forms of the disease, as such advanced forms 
become a clear indication for surgical procedures [4].
On the other hand, the study evaluated only single 
parameters, e.g., the nature of the flow in large arterial 
trunks or some aspects of skin perfusion, possibly with 
vasomotion bonds or flow-mediated endothelium-de-
pendent vasodilation [5–7]. In addition, the studies were 
carried out on small groups of patients, usually not 
exceeding 50 subjects.
The difficulty defining explicit and universally recog-
nized standards of flow in the microcirculation makes it 
hard to develop some useful criteria to assess the impact 
of revascularization on peripheral perfusion. Therefore 
it is impossible to divide the changes observed in the 
postoperative period into the categories of “improve-
ment” or “deterioration”.
In order to deal with such a disadvantage, microcir-
culatory parameters occurring in patients with varying 
severity of the symptoms of atherosclerotic ischaemia 
of the lower limbs were compared with those of healthy 
subjects.
Material and methods
The study included patients with haemodynamically 
significant lesions or occlusions present in the femo-
ral-popliteal section, with the ankle-brachial index value 
lower than 0.9. On the basis of the clinical symptoms, 
patients were included in two study groups:
— Group 1 included 137 patients with symptoms of 
chronic atherosclerotic ischaemia of the lower limbs 
in category 3 and 4 according to the Rutherford 
classification;
— Group 2 included 79 patients with symptoms of 
chronic atherosclerotic ischaemia of the lower limbs 
in category 0 and 1 according to the Rutherford 
classification.
The control group (Group 3) consisted of 27 volun-
teers with no clinically perceptible presence of athero-
sclerotic lesions in coronary and peripheral vessels. All 
subjects underwent electrocardiography at rest, dual 
Doppler imaging of the carotid and vertebral arteries 
and of the lower limbs; their ankle-brachial indexes 
were specified (ABPI > 0.9).
Study exclusion factors included: the presence of 
haemodynamically significant lesions in the iliac, com-
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mon femoral, popliteal, tibial and sagittal arteries; the 
presence of ulceration or necrotic lesions on the limbs; 
pregnancy; chronic venous insufficiency; renal failure 
requiring dialysis; neoplastic, allergic, rheumatic or in-
flammatory diseases; diffuse dermatological lesions; 
uncontrolled or untreated arterial hypertension and 
vasomotor disorders; past ischaemic or haemorrhagic 
cerebral stroke, spinal or spinal cord injury; past phar-
macological treatments or operational sympathectomy; 
limb oedema, regardless of its aetiology; intake of ste-
roid, immunosuppressant, vasomotor or phlebotropic 
medications.
All patients in all study groups received a single 
anti-aggregation drug (Acetylsalicylic acid at a dose of 
100–150 mg/day or Clopidogrel 1 × 75 mg) and statins 
(Simvastatin or Atorvastatin at a dose of 20–40 mg/day) 
as part of pharmacotherapy. Patients with arterial hyper-
tension were treated without the use of beta-blockers 
or calcium antagonists.
Patients from the study groups and the control group 
with arterial hypertension, diabetes or hyperlipidaemia 
were properly treated as part of the pharmacotherapy. 
Proper treatment was confirmed by inspections carried 
out in the form of multiple measurements of arterial 
blood pressure, lipid management profile, blood glucose 
and glycated haemoglobin levels. The characteristics of 
patients included in each group are presented in Table 1.
Table 1. Characteristics of treatment groups and the control 
group
Tabela 1. Charakterystyka grup leczonej i kontrolnej
Group
1 2 3
Number of people 137 79 27
Women/men
number (percent)
40/97
(29.2/70.8)
25/54
(31.6/68.4)
11/16
(33.3/66.7)
Age — mean ± SD 63.3 ± 14.2 66.2 ± 9.9 59.9 ± 12.6
BMI — mean ± SD 25.7 ± 5.9 25.9 ± 4.6 24.9 ± 4.3
Dyslipidaemia
number (percent)
109
(79.6)
55
(69.6)
16
(59.2)
Arterial hypertension
number (percent)
86
(62.8)
46
(58.2)
13
(48.1)
Smoking
number (percent)
94
(68.6)
54
(68.4)
19
(70.4)
Diabetes
number (percent)
39
(26.3)
15
(18.9)
6
(22.2)
Ischaemic heart disease
number (percent)
95
(69.3)
50
(63.3)
0
(0)
Renal failure
number (percent)
6
(4.4)
4
(5.1)
2
(7.4)
Testing methodology
All tests were performed in the morning, in air-con-
ditioned room, at a fixed temperature of 21°C, in the 
supine position, after a 15-minute rest. Patients were 
advised to abstain from caffeinated beverages and/or 
theine and alcoholic beverages for at least 2 hours and 
to avoid physical exercise making them exceed the 
distance of painless passage within 6 hours prior to 
testing. The last doses of hypotensive medications were 
taken by the patients at least 12 hours prior to testing.
All patients had their ankle-brachial indexes meas-
ured. The location and extent of atherosclerotic lesions 
were determined on the basis of imaging results (duplex 
Doppler, angioCT, angioMRI).
To perform vasomotion analyses, skin blood flow 
(SBF) (in arbitrary perfusion units; 1 PU = 10 mV) 
was measured with a laser Doppler probe (PF 457; 
Perimed, Stockholm, Sweden) at the dorsal side of 
the foot (in the middle between the second and third 
metatarsals). Fast-Fourier transform analysis was per-
formed by means of Perisoft dedicated software (PSW 
version 2.50; Perimed) to determine the contribution 
of the five frequency components (VFB, vasomotion 
frequency band) to the variability of the laser Doppler 
signal [i.e., endothelial, 0,01–0,02 Hz (VFBE); neuro-
genic, 0,02–0,06 Hz (VFBN); myogenic, 0,06–0,15 Hz 
(VFBM); respiratory, 0,15–0,40 Hz (VFBR); and heart-
beat, 0,40–1,60 Hz (VFBH)].
The evaluation was performed at the following 
3 times during each measurement: in the resting con-
dition, during the thermal stimulation test (44°C) and 
after post-ischaemic hyperaemia [8]. The results of the 
skin flowmotion assessment are presented in Power 
Density Units [PU/Hz] [9].
 Percutaneous O2 pressure measurement (TcpO2) 
was performed using a Clark electrode (tc electrode 
REF 945-605, E 5250-TcpO2, Radiometer Medicals Aps, 
Denmark) and the PF 5040 TcpO2/pCO2 module of the 
Periflux System 5000. 
Determination of flow-mediated vasodilation
Determination of flow-mediated vasodilation was 
performed according to the recommendations of the 
International Brachial Artery Reactivity Task Force [10]. 
Calculations related to endothelial-dependent flow-me-
diated dilation (FMD) and flow-mediated endothe - 
lium-independent vasodilation after the administration 
of nitroglycerin (NMD).
 Before the study, approval was obtained from the 
local bioethics committee of the Medical University of 
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Poznan. STATISTICA v.9 from StatSoft was used for 
statistical analysis. The Mann-Whitney test for group 
comparisons and the Wilcoxon test for measurement 
comparisons within groups were used. Additionally, 
the Spearman correlation index was used, and values 
of p < 0.05 were considered statistically significant. 
Results
The mean ABI values were 0.53 ± 0.2 in Group 1; 
0.75 ± 0.13 in Group 2 and 1.0 ± 0.05 in the control 
group. The values differed significantly between the 
specific groups (Table 2).
When analysing the relationship between the va-
lues of the studied parameters and the comorbidities 
and risk factors, two significant differences were 
observed:
— diabetic patients from Group 2 showed a significant 
deterioration in the value of endothelium-dependent 
flow-mediated vasodilation (FMD) (Table 3);
— smokers from Group 3 showed a significant decre-
ase in the value of transcutaneous partial pressure 
of oxygen (Table 4).
Except for the above-mentioned situations, the im-
pact of comorbidities and risk factors on microcircula-
tory parameters was not observed (Tables 3–5).
Comparison of Groups 1 and 3
Significantly lower values than in healthy subjects 
were observed in the patients with advanced forms of 
atherosclerotic ischaemia of the lower limbs:
— at rest — power density of the muscular layer 
bond;
Table 2. Comparison of values and the level of significance for the differences between the distribution of values for the 
characteristics of microcirculation in the members of treatment groups
Tabela 2. Porównanie wartości i poziomu istotności dla różnic między rozkładem wartości charakteryzującej mikrokrążenie 
w poszczególnych grupach
Study parameter Units Study group Significance level (p)
1 2 3 2 vs. 3 1 vs. 3 1 vs. 2
Conditions at rest SBF PU 12.05 ± 3.45 12.05 ± 3.45 12.16 ± 6.80 0.174 0.052 0.271
VFBE PU/Hz 1.06 ± 0.41 1.06 ± 0.41 1.01 ± 0.72 0.173 0.443 0.164
VFBN PU/Hz 1.15 ± 0.69 1.15 ± 0.69 1.28 ± 0.56 0.509 0.159 0.546
VFBM PU/Hz 1.33 ± 0.65 1.33 ± 0.65 1.50 ± 0.91 0.690 0.002 < 0.001
VFBR PU/Hz 0.41 ± 0.17 0.41 ± 0.17 0.41 ± 0.19 0.617 0.918 0.433
VFBH PU/Hz 0.62 ± 0.28 0.62 ± 0.28 0.58 ± 0.39 0.192 0.465 0.328
VFB PU/Hz 4.57 ± 1.16 4.57 ± 1.16 4.78 ± 2.13 0.664 0.207 0.001
Thermal stimulation test SBF PU 75.05 ± 24.43 75.05 ± 24.43 136.05 ± 58.2 < 0.001 < 0.001 < 0.001
VFBE PU/Hz 6.59 ± 3.39 6.59 ± 3.39 8.61 ± 7.28 0.340 < 0.001 < 0.001
VFBN PU/Hz 2.37 ± 1.53 2.37 ± 1.53 2.75 ± 1.24 0.285 0.012 0.204
VFBM PU/Hz 2.98 ± 1.31 2.98 ± 1.31 4.15 ± 2.16 0.018 < 0.001 < 0.001
VFBR PU/Hz 1.20 ± 0.70 1.20 ± 0.70 1.23 ± 0.61 0.609 0.259 0.580
VFBH PU/Hz 5.38 ± 2.38 5.38 ± 2.38 5.87 ± 4.14 0.728 0.690 0.186
VFB PU/Hz 18.51 ± 5.03 18.51 ± 5.03 22.61 ± 11.96 0.498 < 0.001 < 0.001
Ischaemic stimulation test SBF PU 62.30 ± 27.93 62.30 ± 27.93 60.88 ± 32.32 0.664 < 0.001 < 0.001
VFBE PU/Hz 2.15 ± 1.06 2.15 ± 1.06 2.45 ± 1.80 0.957 0.014 < 0.001
VFBN PU/Hz 2.85 ± 1.71 2.85 ± 1.71 3.07 ± 1.66 0.977 0.334 0.483
VFBM PU/Hz 2.14 ± 0.99 2.14 ± 0.99 2.25 ± 1.26 0.939 < 0.001 < 0.001
VFBR PU/Hz 0.97 ± 0.58 0.97 ± 0.58 0.92 ± 0.61 0.526 0.951 0.384
VFBH PU/Hz 4.42 ± 1.98 4.42 ± 1.98 4.30 ± 2.53 0.669 0.821 0.224
VFB PU/Hz 12.53 ± 3.07 12.53 ± 3.07 13.00 ± 5.57 0.931 0.034 < 0.001
Thermal stimulation test index 3.12 ± 1.30 6.39 ± 1.68 12.60 ± 5.97 < 0.001 < 0.001 < 0.001
Ischaemic stimulation test index 2.17 ± 0.97 5.19 ± 1.77 5.48 ± 3.10 0.627 < 0.001 < 0.001
TpcO2 mm Hg 19.76 ± 12.20 47.54 ± 14.86 64.30 ± 7.25 < 0.001 < 0.001 < 0.001
ABPI m2/kg 0.53 ± 0.21 0.75 ± 0.13 1.00 ± 0.05 < 0.001 < 0.001 < 0.001
FMD 4.11 ± 2.02 7.44 ± 2.58 9.33 ± 3.87 0.010 < 0.001 < 0.001
NMD 14.06 ± 3.60 14.03 ± 4.33 19.64 ± 5.99 < 0.001 < 0.001 0.762
Grey highlighting indicates the presence of significant differences in the study parameters
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Table 4. Relationship between the percutaneous measurement of oxygen partial pressure and the risk factors in individual 
groups of patients
Tabela 4. Zależność pomiędzy przezskórnym ciśnieniem parcjalnym tlenu a występowaniem czynników ryzyka 
w poszczególnych grupach
Risk factor Group Yes No p
Number of 
patients
Mean Standard  
deviation
Number of 
patients
Mean Standard  
deviation
mm Hg mm Hg
Smoking 1 94 19.55 12.06 43 20.19 12.61 0.78
2 54 48.11 13.5 25 50.62 17.33 0.21
3 9 66.54 4.18 18 63.18 8.26 0.04
Diabetes 1 39 19.19 12.49 98 19.98 12.14 0.72
2 12 44.59 14.72 67 48.06 14.93 0.46
Arterial hypertension 1 86 19.65 12.35 51 19.93 12.06 0.88
2 46 47.26 12.9 33 47.92 17.42 0.88
Stroke/TIA 1 28 21.14 11.63 109 19.4 12.36 0.3
2 15 16.14 7.69 64 17.44 10.74 0.88
Angina pectoris/ 
/myocardial infarction
1 
2
61 
32
18.07 
47.39
10.73 
13.33
76 
47
21.09 
47.31
13.17 
15.95
0.2 
0.87
Table 3. Relationship between the endothelium-dependent flow-mediated vasodilation (FMD) and the risk factors in individual 
groups of patients
Tabela 3. Zależność pomiędzy wartością wazodylatacji indukowanej przepływem (FMD) a występowaniem czynników ryzyka 
w poszczególnych grupach
Risk factor Group Yes No p
Number of 
patients
Mean Standard  
deviation
Number of 
patients
Mean Standard  
deviation
Smoking 1 94 4.07 1.88 43 4.2 2.3 0.82
2 54 7.4 2.64 25 7.52 2.49 0.62
3 9 10.08 2.71 18 8.95 4.35 0.17
Diabetes 1 39 3.02 1.57 98 4.54 2.02 <0.05
2 12 6.43 1.67 67 7.62 2.68 0.16
Arterial hypertension 1 86 4.07 2.06 51 4.17 1.96 0.65
2 46 7.65 2.81 33 7.14 2.22 0.64
Stroke/TIA 1 28 4.27 2.22 109 4.07 1.97 0.68
2 15 4.55 2.53 64 4.37 2.09 0.89
Angina pectoris/ 
/myocardial infarction
1 
2
61 
32
3.94 
7.58
1.74 
2.42
76 
47
4.24 
7.35
2.15 
2.7
0.59 
0.51
— at thermal stimulation — cutaneous blood flow, 
power density of the endothelial, neurogenic and 
myogenic vasomotion frequency bonds and the 
thermal stimulation test index;
— at ischaemic stimulation — cutaneous blood flow, 
power density of the endothelial and myogenic va-
somotion frequency bonds and the ischaemic sti-
mulation test index;
— flow-mediated endothelium-dependent vasodila-
tion; 
— transcutaneous partial pressure of oxygen (Table 2).
Comparison of Groups 1 and 2
Significantly lower values than in Group 2 subjects 
were observed in Group 1 patients:
— at rest – power density of the muscular layer bond;
— at thermal stimulation — cutaneous blood flow, power 
density of the endothelial and myogenic vasomotion 
frequency bonds and the thermal stimulation test index;
— at ischaemic stimulation — cutaneous blood flow, 
power density of the endothelial and myogenic va-
somotion frequency bonds and the ischaemic sti-
mulation test index;
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— both the endothelium-dependent and endothelium-
-independent flow-mediated vasodilation;
— transcutaneous partial pressure of oxygen (Table 2).
Comparison of Groups 2 and 3
The values of perfusion at rest and in ischaemic sti - 
mulation test were comparable between the groups. Sig-
nificant differences were revealed during the thermal 
stimulation test. Cutaneous blood flow was lower in 
healthy people, and power density of the muscular 
layer bonds and the thermal stimulation test index were 
lower in Group 2 (Tables 2–4).
FMD, NMD, TcpO2 and ABPI values were signifi-
cantly lower in patients from Group 2. All other values 
of perfusion were comparable in the study populations 
(Table 2).
Discussion
Including subjects with risk factors for atheroscle-
rosis into the control group, which was adopted in this 
study, is not a routine procedure. In most studies related 
to microcirculation in patients with atherosclerosis, the 
reference system is formed by healthy people with no 
risk factors [11, 12]. However, we considered that to be 
inappropriate, as the modifying influence of risk factors, 
particularly of diabetes and smoking, on the para meters 
of the flow in microcirculation has been already con-
firmed. Please note that the only possible effect of 
revascularization is to restore the normal flow in the 
main arterial trunks. Therefore, after a haemodynami-
cally successful revascularization, the newly-formed 
group, a population comparable to our Groups 2 and 3, 
includes patients with no significant disturbances in the 
flow but with risk factors present.
We did not observe significant differences in the 
value of cutaneous flow at rest or in stimulation tests; no 
significant differences were also observed in the power 
density of individual vasomotion bonds in patients with 
and without diabetes. Such a relationship only occurred 
in relation to the value of endothelium-dependent 
flow-mediated vasodilation.
However, it should be noted that correct results 
observed in laser-Doppler flowmetry do not confirm 
the absence of changes in the microciculatory function. 
According to Jorneskog, evaluation of microcircula-
tory flow only on the basis of laser-Doppler flowmetry 
is insufficient for PAOD stage II patients with diabe-
tes. Cutaneous blood flow, both at rest and in ischaemic 
stimulation test, often assumes values falling within the 
broad range of standards, despite the clinically observed 
tendency to form skin ulcerations. A flattened conges-
tion phase wave in the ischaemic stimulation test was 
observed only in some cases. In this case, it may be 
helpful to perform videometric capillaroscopy, allow-
ing to demonstrate that the normal amount of blood 
reaching the feet passes through the arterio-venous 
anastomoses and does not reach the capillaries [13].
Isolated abnormalities of the vasomotion bond, de-
pendent on sympathetic fibres, were found in relation to 
the patients with diabetes [14]. It turned out then that the 
analysis of the vasomotion bonds is a tool more accurate 
to study the risk of developing diabetic foot than neu-
Table 5. Relationship between the flow-mediated non-endothelium dependent vasodilation (NMD) and the risk factors in 
individual groups of patients
Tabela 5. Zależność pomiędzy wazodylatacją niezależną od śródbłonka (NMD) a występowaniem czynników ryzyka 
w poszczególnych grupach
Risk factor Group Yes No p
Number of 
patients
Mean Standard  
deviation
Number of 
patients
Mean Standard  
deviation
Smoking 1 94 14.29 3.52 43 13.55 3.74 0.36
2 54 13.97 4.15 25 14.16 4.76 0.86
3 9 20.63 5.63 18 14.14 6.26 0.79
Diabetes 1 39 14.81 4.18 98 13.76 3.31 0.12
2 12 15.42 4.63 67 13.78 4.25 0.23
Arterial hypertension 1 86 14.05 3.73 51 14.06 3.37 0.99
2 46 14.14 3.62 33 13.88 5.2 0.6
Stroke/TIA 1 28 14.62 3.59 109 13.91 3.59 0.35
2 15 14.04 3.24 64 13.76 3.38 0.78
Angina pectoris/ 
/myocardial infarction
1 
2
61 
32
14.13 
14.5
3.73 
4.07
76 
47
13.99 
13.71
3.51 
4.5
0.82 
0.42
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rological tests [15]. Diabetes-related impairment of the 
sympathetic nerve function (neuropathy) may determine 
the increase in the microcirculatory flow, especially on 
the feet and lower legs during longer periods of standing. 
Clinically, this condition may result in the development 
of persistent knee joint oedema [16]. 
However, the presence of diabetes did not have 
any impact on the changes in the peripheral perfusion 
in patients undergoing haemodialysis in the course of 
chronic renal failure. The range of changes observed 
during dialysis and related to significant decrease in 
peri-ankle tension, thermal stimulation test index and 
transcutaneous partial pressure of oxygen was compa-
rable in both groups of patients, i.e. with and without 
diabetes [12].
Our analysis showed no differences in the distribu-
tion of power density of individual vasomotion bonds 
between the patients with newly diagnosed and per-
sistent arterial hypertension, as compared with healthy 
subjects. Also, other authors did not observe any signifi-
cant differences in the values of skin flow at rest or after 
stimulation tests between subjects with and without 
arterial hypertension [17–19]. Such differences were 
demonstrated during studies on vasomotion bonds. In 
the case of newly diagnosed arterial hypertension, in-
crease in the power density for the endothelial bond, 
with no changes in the power density values for the 
myogenic and neurogenic bonds, was observed in ther-
mal stimulation test. In contrast, patients with persistent 
arterial hypertension exhibited increases in the power 
density of the myogenic bond and no simultaneous in-
crease in the value of power density for the endothelial 
or neurogenic bonds [18]. Such a distribution of results 
indicates a progressive impairment of endothelial func-
tion under the influence of persistent arterial hyperten-
sion. The restoration of the muscle function to generate 
vasomotion observed in a later period is interpreted 
as a positive effect of hypotensive therapy, with no 
simultaneous improvement, even after the endothelial 
bond fades out [17].
The third risk factor that could affect microcircula-
tory parameters is smoking. Decrease in the value of 
transcutaneous partial pressure of oxygen in smo kers 
was observed only in the group of healthy subjects. We 
did not find any differences between smokers and 
non-smokers, regardless of the severity of their clini-
cal symptoms.
Similar observations were also reported by Edvins-
son [20]. However, Rossi did not observe any significant 
differences in skin flow values or power density of 
individual vasomotion bonds under resting conditions 
but he found a significant reduction in the value and 
power density of the endothelial, myogenic and neuro-
genic bonds in smokers, as compared to non-smokers 
[21]. Such a change in the perfusion parameters serves 
as evidence of significant impairment of the endothe-
lial and muscular functions and the way in which hu-
man sympathetic system works under the influence 
of smoking. The decisive role of impaired endothelial 
function by nicotine was confirmed by Celermajer [22]. 
Examining a group of male subjects under the age of 
30, who were active or passive smokers, he showed 
a decrease of flow-mediated endothelium-dependent 
vasodilation with no significant changes during a test 
with nitroglycerin which is a factor decontracting the 
vessels independently of the endothelium.
In respect of the clinical assessment of limb perfu-
sion, it was interesting to observe a comparable value 
of resting skin blood flow in the limbs of healthy sub-
jects (Group 3) and smaller (Group 2) and advanced 
(Group 1) atherosclerotic lesions. The phenomenon 
of similar values of skin blood flow can be explained by 
the important role which is played by the skin vessels 
in the creation of collateral circulation in patients with 
advanced forms of atherosclerotic lesions in subfascial 
arterial trunks. Despite muscle ischaemia, the appear-
ance and warmth of the skin may remain unchanged, 
which can make it difficult to decide about the need/re-
commendation to perform revascularization in patients 
with short-distance claudication but appropriate limb 
warmth [23]. Therefore it would be advisable to per-
form provocative tests, e.g. thermal stimulation test and 
ischaemic stimulation test, which indicate the impair-
ment of the functional microcirculatory reserve. The 
scope of impairment increases in proportion to the 
severity of clinical symptoms of ischaemia.
Conclusions
The occurrence of mild forms of PAOD is associa-
ted with a worse systemic vascular function expressed 
as a reduction in the scope of flow-mediated vasodila-
tion and locally in TcpO2 decrease. The occurrence 
of advanced forms of ischaemia was accompanied 
by a significant severity of local symptoms, mainly in 
the form of further reduction in TcpO2 and a drastic 
reduction or exhaustion of the functional microcircu-
latory reserve.
Among the evaluated risk factors for atheroscle-
rosis only diabetes and smoking significantly modified 
perfusion, which resulted in a significant decrease in 
the values of flow-mediated vasodilation and TcpO2.
Microcirculation characteristics in patients with vary - 
ing severity of atherosclerotic lesions may be helpful 
in evaluating revascularization procedures effective-
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ness. Cutaneous blood flow maintenance in patients 
with advanced forms of PAOD indicates that clinical 
assessment of ischaemic limbs may be insufficient at 
the initial qualification of PAOD patients to surgical 
treatment.
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